Esomeprazole potassium is a proton pump inhibitor used for the treatment of gastroesophageal reflux disease (GERD) by inhibiting gastric acid secretion through suppression of H⁺,K⁺-ATPase in gastric parietal cells; it has also been studied for its potential in suppressing triple-negative breast cancer cell growth in vitro via induction of intracellular acidification; additionally, it demonstrates anti-fibrotic effects in vivo, significantly inhibiting lung fibrosis progression and reducing circulating markers of inflammation and fibrosis in murine models of smoke-induced lung injury.